Afraxis, Inc.
Records under this name other than patents Afraxis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Afraxis, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,977,024 | Distributed anatomical image analysis Lapsed on the fee record Ended Mar 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2023 | From the USPTO record |
| US 8,912,203 | 6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders Lapsed on the fee record Ended Dec 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 16, 2018 | From the USPTO record |
| US 8,680,099 | 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders Lapsed on the fee record Ended Mar 25, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 25, 2018 | From the USPTO record |
| US 8,674,095 | Compounds for treating neuropsychiatric conditions Lapsed on the fee record Ended Mar 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2018 | From the USPTO record |
| US 8,372,970 | 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders Lapsed on the fee record Ended Feb 12, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 12, 2017 | From the USPTO record |